Nanosonics Limited (ASX:NAN)

Market Cap	1.03B -23.3%
Revenue (ttm)	207.26M +12.7%
Net Income	20.56M +24.1%
EPS	0.07 +24.7%
Shares Out	300.79M
PE Ratio	51.58
Forward PE	53.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	618,034
Average Volume	1,105,944
Open	3.410
Previous Close	3.430
Day's Range	3.410 - 3.480
52-Week Range	3.210 - 5.180
Beta	1.57
RSI	45.58
Earnings Date	Feb 23, 2026

About Nanosonics

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 470
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NAN

Financial Performance

In fiscal year 2025, Nanosonics's revenue was 198.63 million, an increase of 16.83% compared to the previous year's 170.01 million. Earnings were 20.68 million, an increase of 59.39%.